Guidant's Duet Stent Paces 34% Growth In Vascular Intervention Sales
This article was originally published in The Gray Sheet
Executive Summary
Guidant's Multi-Link Duet coronary stent garnered nearly half of the U.S. stent market in the third quarter of 1999, the company reported Oct. 14, pacing a 34% growth in the company's vascular intervention business to $290.1 mil.